American Society For Clinical Pharmacology & Therapeutics is a 501(c)(3) organization based in Alexandria, Virginia, registered in 1973, with $4,291,389 in FY2024 revenue. CharityIndex grades it B.
Revenue (FY2024)
$4.3M
▲ 16.0% vs prior year
Health median: $840K
Expenses (FY2024)
$4.2M
Net assets
$6.7M
Employees
—
Rated on 2 of 4 criteria — the rest aren't reported in this filing type.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for American Society For Clinical Pharmacology & Therapeutics— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For American Society For Clinical Pharmacology & Therapeutics: 19 mo reserves · +3% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for American Society For Clinical Pharmacology & Therapeutics— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For American Society For Clinical Pharmacology & Therapeutics: 2 of 5 disclosure signals earns a C on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue grew from $2.8M (FY2013) to $4.3M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
2.9%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$7.7M
Total liabilities
$990K
Net assets
$6.7M
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $4,291,389▲16.0% | $4,166,644▲2.8% | $6,735,585▲3.8% | $7,725,742▲19.0% | 990 |
| 2023 | $3,700,370▲2.1% | $4,053,559▲24.6% | $6,491,449▼0.2% | $6,491,449▼0.2% | 990 |
| 2022 | $3,625,776▼15.3% | $3,254,073▼1.0% | $6,502,007▼2.0% | $6,502,007▼2.0% | 990 |
| 2021 | $4,282,201▲103% | $3,287,407▲23.2% | $6,637,281▲25.3% | $6,637,281▲25.3% | 990 |
| 2020 | $2,105,682▼47.5% | $2,668,717▼27.5% | $5,298,284▼8.1% | $5,298,284▼8.9% | 990 |
| 2019 | $4,011,186▲5.6% | $3,682,303▲3.0% | $5,765,207▲12.2% | $5,817,074▲12.0% | 990 |
| 2018 | $3,798,624▲8.9% | $3,575,493▼2.7% | $5,139,980▲0.7% | $5,194,739▲1.0% | 990 |
| 2017 | $3,489,349▼3.1% | $3,673,213▼1.8% | $5,102,287▼0.7% | $5,142,500▼2.4% | 990 |
| 2016 | $3,599,868▲22.6% | $3,740,444▲15.0% | $5,138,868▼1.1% | $5,268,980▼1.9% | 990 |
| 2015 | $2,935,595▼11.4% | $3,253,137▲17.5% | $5,197,907▼7.1% | $5,370,032▼7.6% | 990 |
| 2014 | $3,313,990▲19.7% | $2,769,298▲3.9% | $5,594,818▲12.5% | $5,813,029▲11.2% | 990 |
| 2013 | $2,768,829 | $2,666,553▼9.7% | $4,974,333▲6.2% | $5,226,153▲5.0% | 990 |
| 2012 | — | $2,954,312▲14.4% | $4,683,325▲8.8% | $4,977,245▲7.2% | 990 |
| 2011 | — | $2,583,442▼0.1% | $4,305,539▲0.9% | $4,643,996▲0.3% | 990 |
| 2010 | — | $2,586,307 | $4,267,635 | $4,628,658 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Explore more
Data for American Society For Clinical Pharmacology & Therapeutics (EIN 23-1682043) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.